LSP-249 (example 35)，信息来自专利WO2016011209A1，是血浆kallikrein 的抑制剂，用于血管性水肿的研究，EC50 值小于 100 nM。
货号:ajcx34242
CAS:1801253-04-2
分子式:C24H22ClN5O
分子量：431.92
溶解度:DMSO : 31.25 mg/mL (72.35 mM; ultrasonic and warming and heat to 60°C)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1].

[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.